Events & Presentations Upcoming Events 43rd Annual J.P. Morgan Healthcare Conference Jan 15, 2025 at 7:30 AM PST Click here for webcast Add to Outlook Add to Google Calendar Past Events Stifel Healthcare Conference Nov 18, 2024 at 2:25 PM EST Click here for webcast Investor Presentations ARS Pharma Corporate Presentation ARS Pharma Corporate Presentation 6.1 MB Aug 9, 2024 neffy® FDA Approval Call On August 9, 2024, we announced the FDA approval of neffy for adults and children 30 kg or greater in body weight. Supporting Materials neffy FDA Approval Call (August 2024) 5.9 MB Mar 7, 2024 at 1:00 PM EST Neffy® Investor Day On March 7, 2024, we hosted a virtual neffy Investor Day event showcasing the neffy product profile and anticipated commercialization strategy, including presentations from ARS Pharma senior management, as well as guest speakers. To view the webcast, click here Supporting Materials neffy investor day presentation (Mar 2024) 10.1 MB Scientific Publications JACI: In Practice Self-Administration Dosing Publication Adult pharmacokinetics of self-administration of epinephrine nasal spray 2.0 mg… JACI 2023 Single and Repeat Dose Publication Pharmacokinetics/pharmacodynamics of epinephrine after single and repeat admini… Scientific Presentations AAAAI 2023 Poster 28 Epinephrine Auto-Injector (EAI) Prescriptions Are Not Filled Due to Dislike of Needles: Results of a Patient Survey 2.2 MB AAAAI 2022 Poster 008 Comparison of Pharmacokinetic Parameters and Intra-Blood Vessel Injection Rates Between Manual Intramuscular Injection and Epinephrine Auto-Injectors 333.1 KB ACAAI 2022 Poster 008 Epinephrine Via Needle-Free Device Would Be Administered Faster After Symptoms: Results of a Patient/Caregiver Survey 1.1 MB Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3
Investor Presentations ARS Pharma Corporate Presentation ARS Pharma Corporate Presentation 6.1 MB Aug 9, 2024 neffy® FDA Approval Call On August 9, 2024, we announced the FDA approval of neffy for adults and children 30 kg or greater in body weight. Supporting Materials neffy FDA Approval Call (August 2024) 5.9 MB Mar 7, 2024 at 1:00 PM EST Neffy® Investor Day On March 7, 2024, we hosted a virtual neffy Investor Day event showcasing the neffy product profile and anticipated commercialization strategy, including presentations from ARS Pharma senior management, as well as guest speakers. To view the webcast, click here Supporting Materials neffy investor day presentation (Mar 2024) 10.1 MB Scientific Publications JACI: In Practice Self-Administration Dosing Publication Adult pharmacokinetics of self-administration of epinephrine nasal spray 2.0 mg… JACI 2023 Single and Repeat Dose Publication Pharmacokinetics/pharmacodynamics of epinephrine after single and repeat admini… Scientific Presentations AAAAI 2023 Poster 28 Epinephrine Auto-Injector (EAI) Prescriptions Are Not Filled Due to Dislike of Needles: Results of a Patient Survey 2.2 MB AAAAI 2022 Poster 008 Comparison of Pharmacokinetic Parameters and Intra-Blood Vessel Injection Rates Between Manual Intramuscular Injection and Epinephrine Auto-Injectors 333.1 KB ACAAI 2022 Poster 008 Epinephrine Via Needle-Free Device Would Be Administered Faster After Symptoms: Results of a Patient/Caregiver Survey 1.1 MB Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3
Epinephrine Auto-Injector (EAI) Prescriptions Are Not Filled Due to Dislike of Needles: Results of a Patient Survey 2.2 MB
Comparison of Pharmacokinetic Parameters and Intra-Blood Vessel Injection Rates Between Manual Intramuscular Injection and Epinephrine Auto-Injectors 333.1 KB
Epinephrine Via Needle-Free Device Would Be Administered Faster After Symptoms: Results of a Patient/Caregiver Survey 1.1 MB
